Table 1. OTC Transdermal Analgesic Patches Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. OTC Transdermal Analgesic Patches Market Restraints

Table 3. OTC Transdermal Analgesic Patches Market Trends

Table 4. OTC Transdermal Analgesic Patches Industry Policy

Table 5. Global OTC Transdermal Analgesic Patches Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global OTC Transdermal Analgesic Patches Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global OTC Transdermal Analgesic Patches Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global OTC Transdermal Analgesic Patches Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global OTC Transdermal Analgesic Patches Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global OTC Transdermal Analgesic Patches Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global OTC Transdermal Analgesic Patches Mergers & Acquisitions, Expansion Plans

Table 12. Global OTC Transdermal Analgesic Patches Manufacturers Product Type

Table 13. Head Office and OTC Transdermal Analgesic Patches Production Site of Key Manufacturer

Table 14. OTC Transdermal Analgesic Patches Capacity of Major Manufacturers and Future Plan

Table 15. China OTC Transdermal Analgesic Patches Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China OTC Transdermal Analgesic Patches Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China OTC Transdermal Analgesic Patches Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global OTC Transdermal Analgesic Patches Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global OTC Transdermal Analgesic Patches Production by Region, 2018-2023, (K Units)

Table 20. Global OTC Transdermal Analgesic Patches Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of OTC Transdermal Analgesic Patches Upstream (Raw Materials)

Table 22. Global OTC Transdermal Analgesic Patches Typical Customers

Table 23. OTC Transdermal Analgesic Patches Typical Distributors

Table 24. By Type, Global OTC Transdermal Analgesic Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global OTC Transdermal Analgesic Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global OTC Transdermal Analgesic Patches Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global OTC Transdermal Analgesic Patches Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global OTC Transdermal Analgesic Patches Consumption Value Market Share, 2018-2029

Table 32. By Country, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2018-2029

Table 34. Hisamitsu Company Information, Head Office, Market Area, and Industry Position

Table 35. Hisamitsu OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 36. Hisamitsu OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Hisamitsu Company Profile and Main Business

Table 38. Hisamitsu Recent Developments

Table 39. Mylan Company Information, Head Office, Market Area, and Industry Position

Table 40. Mylan OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 41. Mylan OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Mylan Company Profile and Main Business

Table 43. Mylan Recent Developments

Table 44. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position

Table 45. Johnson & Johnson OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 46. Johnson & Johnson OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Johnson & Johnson Company Profile and Main Business

Table 48. Johnson & Johnson Recent Developments

Table 49. Teva Company Information, Head Office, Market Area, and Industry Position

Table 50. Teva OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 51. Teva OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Teva Company Profile and Main Business

Table 53. Teva Recent Developments

Table 54. Lingrui Company Information, Head Office, Market Area, and Industry Position

Table 55. Lingrui OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 56. Lingrui OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Lingrui Company Profile and Main Business

Table 58. Lingrui Recent Developments

Table 59. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 60. Sanofi OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 61. Sanofi OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Sanofi Company Profile and Main Business

Table 63. Sanofi Recent Developments

Table 64. Qizheng Company Information, Head Office, Market Area, and Industry Position

Table 65. Qizheng OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 66. Qizheng OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Qizheng Company Profile and Main Business

Table 68. Qizheng Recent Developments

Table 69. Endo Company Information, Head Office, Market Area, and Industry Position

Table 70. Endo OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 71. Endo OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Endo Company Profile and Main Business

Table 73. Endo Recent Developments

Table 74. Huarun 999 Company Information, Head Office, Market Area, and Industry Position

Table 75. Huarun 999 OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 76. Huarun 999 OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Huarun 999 Company Profile and Main Business

Table 78. Huarun 999 Recent Developments

Table 79. GSK Company Information, Head Office, Market Area, and Industry Position

Table 80. GSK OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 81. GSK OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. GSK Company Profile and Main Business

Table 83. GSK Recent Developments

Table 84. Haw Par Company Information, Head Office, Market Area, and Industry Position

Table 85. Haw Par OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 86. Haw Par OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Haw Par Company Profile and Main Business

Table 88. Haw Par Recent Developments

Table 89. Nichiban Company Information, Head Office, Market Area, and Industry Position

Table 90. Nichiban OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 91. Nichiban OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Nichiban Company Profile and Main Business

Table 93. Nichiban Recent Developments

Table 94. Laboratoires Genevrier Company Information, Head Office, Market Area, and Industry Position

Table 95. Laboratoires Genevrier OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 96. Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Laboratoires Genevrier Company Profile and Main Business

Table 98. Laboratoires Genevrier Recent Developments

Table 99. BLUE-EMU Company Information, Head Office, Market Area, and Industry Position

Table 100. BLUE-EMU OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 101. BLUE-EMU OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. BLUE-EMU Company Profile and Main Business

Table 103. BLUE-EMU Recent Developments

Table 104. IBSA Group Company Information, Head Office, Market Area, and Industry Position

Table 105. IBSA Group OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 106. IBSA Group OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. IBSA Group Company Profile and Main Business

Table 108. IBSA Group Recent Developments

Table 109. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 110. Pfizer OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 111. Pfizer OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 112. Pfizer Company Profile and Main Business

Table 113. Pfizer Recent Developments

Table 114. Performance Health Company Information, Head Office, Market Area, and Industry Position

Table 115. Performance Health OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 116. Performance Health OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 117. Performance Health Company Profile and Main Business

Table 118. Performance Health Recent Developments

Table 119. Actavis Company Information, Head Office, Market Area, and Industry Position

Table 120. Actavis OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 121. Actavis OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 122. Actavis Company Profile and Main Business

Table 123. Actavis Recent Developments

Table 124. Teikoku Seiyaku Company Information, Head Office, Market Area, and Industry Position

Table 125. Teikoku Seiyaku OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 126. Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 127. Teikoku Seiyaku Company Profile and Main Business

Table 128. Teikoku Seiyaku Recent Developments

Table 129. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 130. Novartis OTC Transdermal Analgesic Patches Models, Specifications, and Application

Table 131. Novartis OTC Transdermal Analgesic Patches Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 132. Novartis Company Profile and Main Business

Table 133. Novartis Recent Developments

List of Figures

Figure 1. OTC Transdermal Analgesic Patches Picture

Figure 2. Global OTC Transdermal Analgesic Patches Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global OTC Transdermal Analgesic Patches Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global OTC Transdermal Analgesic Patches Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China OTC Transdermal Analgesic Patches Consumption Value, (US$ million) & (2018-2029)

Figure 6. China OTC Transdermal Analgesic Patches Sales Quantity (K Units) & (2018-2029)

Figure 7. China OTC Transdermal Analgesic Patches Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China OTC Transdermal Analgesic Patches Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China OTC Transdermal Analgesic Patches Market Share of Global, 2018-2029

Figure 10. Global OTC Transdermal Analgesic Patches Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China OTC Transdermal Analgesic Patches Key Participants, Market Share, 2022

Figure 12. Global OTC Transdermal Analgesic Patches Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global OTC Transdermal Analgesic Patches Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global OTC Transdermal Analgesic Patches Production Market Share & Forecast by Region, 2018-2029

Figure 15. OTC Transdermal Analgesic Patches Industry Chain

Figure 16. OTC Transdermal Analgesic Patches Procurement Model

Figure 17. OTC Transdermal Analgesic Patches Sales Model

Figure 18. OTC Transdermal Analgesic Patches Sales Channels, Direct Sales, and Distribution

Figure 19. Lidocaine Patches

Figure 20. Diclofenac Patches

Figure 21. Indomethacin Patches

Figure 22. Counter-Irritant Patches

Figure 23. Others

Figure 24. By Type, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029, US$ Million

Figure 25. By Type, Global OTC Transdermal Analgesic Patches Consumption Value Market Share, 2018-2029

Figure 26. By Type, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Figure 27. By Type, Global OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2018-2029

Figure 28. By Type, Global OTC Transdermal Analgesic Patches Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 29. Pharmacy

Figure 30. Clinic

Figure 31. Others

Figure 32. By Application, Global OTC Transdermal Analgesic Patches Consumption Value, 2018-2029, US$ Million

Figure 33. By Application, Global OTC Transdermal Analgesic Patches Consumption Value Market Share, 2018-2029

Figure 34. By Application, Global OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Figure 35. By Application, Global OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2018-2029

Figure 36. By Application, Global OTC Transdermal Analgesic Patches Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 37. By Region, Global OTC Transdermal Analgesic Patches Consumption Value Market Share, 2018-2029

Figure 38. By Region, Global OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2018-2029

Figure 39. North America OTC Transdermal Analgesic Patches Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 40. By Country, North America OTC Transdermal Analgesic Patches Consumption Value Market Share, 2022

Figure 41. Europe OTC Transdermal Analgesic Patches Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, Europe OTC Transdermal Analgesic Patches Consumption Value Market Share, 2022

Figure 43. Asia Pacific OTC Transdermal Analgesic Patches Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 44. By Country/Region, Asia Pacific OTC Transdermal Analgesic Patches Consumption Value Market Share, 2022

Figure 45. South America OTC Transdermal Analgesic Patches Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, South America OTC Transdermal Analgesic Patches Consumption Value Market Share, 2022

Figure 47. Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 48. U.S. OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Figure 49. By Type, U.S. OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 50. By Application, U.S. OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 51. Europe OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Figure 52. By Type, Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 53. By Application, Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 54. China OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Figure 55. By Type, China OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 56. By Application, China OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 57. Japan OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Figure 58. By Type, Japan OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 59. By Application, Japan OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 60. South Korea OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Figure 61. By Type, South Korea OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 62. By Application, South Korea OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 63. Southeast Asia OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Figure 64. By Type, Southeast Asia OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 65. By Application, Southeast Asia OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 66. India OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Figure 67. By Type, India OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 68. By Application, India OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 69. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity, 2018-2029, (K Units)

Figure 70. By Type, Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 71. By Application, Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share, 2022 VS 2029

Figure 72. Research Methodology

Figure 73. Breakdown of Primary Interviews

Figure 74. Bottom-up and Top-down Approaches

Figure 75. Top-down Approaches